Nondisjunction & Aneuploidy

What actually goes wrong

Every dividing cell faces the same logistical problem: it must hand each daughter exactly one full copy of the genome — no more, no less. In humans that means partitioning 46 chromosomes (23 pairs) so each new cell ends up with the right complement. The machinery that pulls this off is the spindle, a scaffold of microtubules that latches onto each chromosome's kinetochore and reels the copies to opposite poles at anaphase. Nondisjunction is what happens when that segregation fails and two chromosomes that should have gone to opposite poles go to the same one.

There are two distinct moments in meiosis where this can happen, and they produce different patterns:

• Meiosis I nondisjunction. A pair of homologous chromosomes — the maternal and paternal copy of, say, chromosome 21 — fails to disjoin. Both homologs travel to the same pole. After meiosis II, two gametes end up with an extra chromosome and two end up missing one. Because both homologs are present, the resulting trisomy contains chromosomes from both parental copies. The large majority of human trisomies trace to meiosis I errors in the egg.
• Meiosis II nondisjunction. The homologs separated correctly in meiosis I, but the two sister chromatids fail to split in meiosis II. Only two of the four gametes are aneuploid, and the trisomic one carries two identical copies derived from a single homolog.

The same failure in an ordinary somatic division is mitotic nondisjunction. Here sister chromatids fail to separate, so one daughter cell gains a chromosome and the other loses one. If this occurs early in an embryo, it produces mosaicism — a body built from two or more cell lines with different chromosome counts. Later in life, repeated mitotic missegregation produces the chromosomal instability that defines most tumors.

Why does the spindle ever let this slip? Cells have a dedicated guard, the spindle assembly checkpoint (SAC), that halts anaphase until every kinetochore is correctly attached to microtubules from the right pole. A single unattached kinetochore generates a "wait" signal strong enough to pause the entire cell. Nondisjunction occurs when this checkpoint is bypassed, weakened, or satisfied by a mistaken attachment — for example a merotelic attachment, where one kinetochore is grabbed by microtubules from both poles at once. Merotelic attachments are invisible to the checkpoint because the kinetochore looks occupied, yet they pull the chromosome the wrong way.

Aneuploidy: the wrong number of chromosomes

The product of nondisjunction is aneuploidy — a chromosome count that is not an exact multiple of the haploid number. It is worth distinguishing the vocabulary carefully, because these terms are routinely confused:

Term	Chromosome count	Meaning	Human example
Euploid	Exact multiple of n	Complete chromosome sets	Normal diploid 2n = 46
Trisomy	2n + 1 = 47	One extra chromosome	Trisomy 21 (Down)
Monosomy	2n − 1 = 45	One missing chromosome	Turner syndrome (45,X)
Tetrasomy	2n + 2 = 48	Two extra copies of one chromosome	48,XXXX; 48,XXYY
Triploidy (polyploidy)	3n = 69	An entire extra set	69,XXX — almost always lethal

The crucial insight is that an aneuploid cell does not just have one broken gene — it has a dosage imbalance across an entire chromosome. Chromosome 21, the smallest human autosome, still carries on the order of 200–230 protein-coding genes. Adding a third copy nudges the expression of all of them up by roughly 50%, and many cellular pathways are exquisitely sensitive to the relative dose of their components. This is why the phenotype is so broad and systemic: it is the simultaneous mis-tuning of hundreds of genes, not a single mutation.

Dosage sensitivity is also why most aneuploidies never make it to birth. Monosomy of any autosome is essentially always lethal in humans — half the normal dose of an entire chromosome's worth of genes is unsurvivable. Autosomal trisomies are mostly lethal too. The survivable autosomal cases — chromosomes 21, 18, and 13 — are precisely the gene-poorest autosomes, so the dosage shock is smallest.

The survivable aneuploidies

A short list of aneuploidies is compatible with live birth, and they cluster on the smallest autosomes and the sex chromosomes:

Condition	Karyotype	Approx. incidence (live births)	Notes
Down syndrome	Trisomy 21 (47,+21)	~1 in 700	Most common survivable autosomal trisomy
Edwards syndrome	Trisomy 18 (47,+18)	~1 in 5,000	Severe; most die within the first year
Patau syndrome	Trisomy 13 (47,+13)	~1 in 16,000	Severe; high early mortality
Klinefelter syndrome	47,XXY	~1 in 600 males	Extra X buffered by X-inactivation
Turner syndrome	45,X (monosomy X)	~1 in 2,500 females	Only viable human monosomy
Triple X / XYY	47,XXX / 47,XYY	~1 in 1,000	Often mild or asymptomatic

Notice that the sex chromosomes tolerate aneuploidy far better than autosomes. The reason is X-inactivation: mammalian cells silence all but one X chromosome, so an extra X is largely switched off and the dosage imbalance is muted. The Y chromosome carries very few genes, so extra or missing Y material is also better tolerated. Turner syndrome (45,X) is the single human monosomy compatible with life — and even so, the great majority of 45,X conceptions miscarry; only about 1% survive to term.

Why maternal age is the dominant risk factor

The most striking epidemiological fact about nondisjunction is its dependence on the age of the egg. The mechanism is rooted in the unusual timeline of female meiosis. A human female makes all of her oocytes before she is born; they enter meiosis I in fetal life and then arrest in prophase I. They stay frozen in that state — sometimes for more than four decades — until ovulation reactivates one each cycle.

During that long arrest, the only thing holding each homologous pair together is cohesin, a ring-shaped protein complex loaded onto the chromosomes before birth. Crucially, cohesin in oocytes is not topped up after fetal life; the cell must make the original glue last a lifetime. As decades pass, cohesin gradually wears away. When meiosis finally resumes in an aged oocyte, chromosomes that have lost their cohesin tether segregate at random, dramatically raising the chance that both members of a pair go to the same pole. The numbers tell the story:

Maternal age	Risk of trisomy 21 at birth	Risk of any chromosome abnormality
20	~1 in 1,400	~1 in 500
30	~1 in 900	~1 in 380
35	~1 in 350	~1 in 180
40	~1 in 85	~1 in 60
45	~1 in 30	~1 in 20

Paternal age contributes far less to aneuploidy. Sperm are produced continuously from stem cells throughout adult life, so they are never trapped in a decades-long arrest, and male meiosis runs to completion in a matter of days. The vast majority of human trisomies — around 90% for trisomy 21 — are therefore maternal in origin, and most arise specifically in meiosis I.

Nondisjunction beyond reproduction: cancer and CIN

Nondisjunction is not only a reproductive accident. When it recurs in dividing somatic cells, it produces chromosomal instability (CIN) — an ongoing tendency to gain and lose whole chromosomes generation after generation. About 90% of solid tumors and roughly 75% of blood cancers are aneuploid, and CIN is now considered an enabling characteristic of cancer in its own right.

The logic is the same as in the embryo but turned to the tumor's advantage. Each missegregation reshuffles dosage of hundreds of genes at once. A chromosome carrying an oncogene can be gained; one carrying a tumor suppressor can be lost. Because a single nondisjunction event can simultaneously amplify drivers and delete brakes, aneuploidy lets tumor cell populations explore the fitness landscape far faster than point mutations alone would allow. The flip side is that severe aneuploidy is itself stressful — it strains protein folding, metabolism, and the proteasome — which is part of why some anti-cancer strategies aim to push instability past a tolerable threshold rather than suppress it.

Detecting aneuploidy

• Karyotype. The classic test: arrest cells in metaphase, spread and stain the chromosomes, and literally count them. A 47,XX,+21 readout names a trisomy 21 female directly.
• FISH. Fluorescent probes light up specific chromosomes, giving a fast count for the common aneuploidies (13, 18, 21, X, Y) without full culture.
• Chromosomal microarray. Compares DNA copy number across the genome at high resolution, catching whole-chromosome gains as well as smaller deletions and duplications.
• NIPT (non-invasive prenatal testing). Sequences cell-free fetal DNA circulating in maternal blood. A relative excess of chromosome-21 fragments flags a likely trisomy 21 as early as ten weeks — a screening test, confirmed by amniocentesis or chorionic villus sampling.

Why it matters

• Reproductive medicine. Aneuploidy is the single largest known cause of miscarriage and a leading cause of congenital disorders.
• Prenatal screening. The maternal-age curve drives counseling and the choice of screening tests.
• Oncology. Chromosomal instability is a defining and targetable feature of cancer.
• Cell biology. Studying nondisjunction has illuminated the spindle checkpoint, cohesin, and kinetochore biology.
• Evolution. In plants, whole-genome doubling (polyploidy) — distinct from aneuploidy — has repeatedly driven speciation.